vs
Side-by-side financial comparison of FENNEC PHARMACEUTICALS INC. (FENC) and Ladder Capital Corp (LADR). Click either name above to swap in a different company.
Ladder Capital Corp is the larger business by last-quarter revenue ($22.3M vs $13.8M, roughly 1.6× FENNEC PHARMACEUTICALS INC.). Ladder Capital Corp runs the higher net margin — 71.0% vs -34.7%, a 105.8% gap on every dollar of revenue. On growth, FENNEC PHARMACEUTICALS INC. posted the faster year-over-year revenue change (73.8% vs -18.0%). Over the past eight quarters, Ladder Capital Corp's revenue compounded faster (-22.5% CAGR vs -26.3%).
Fennec Pharmaceuticals Inc. is a biopharmaceutical firm focused on developing and commercializing therapies to reduce treatment-related side effects in pediatric cancer patients. Its lead product targets chemotherapy-induced ototoxicity, with core North American markets serving oncology providers and vulnerable pediatric patient groups.
Ladder Capital Corp is a leading commercial real estate finance firm operating primarily across the United States. It originates and manages a diversified portfolio of senior secured commercial mortgage loans, mezzanine debt, commercial mortgage-backed securities, and direct real estate assets, serving property owners, operators and developers across major market segments.
FENC vs LADR — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $13.8M | $22.3M |
| Net Profit | $-4.8M | $15.9M |
| Gross Margin | — | — |
| Operating Margin | -18.5% | 69.5% |
| Net Margin | -34.7% | 71.0% |
| Revenue YoY | 73.8% | -18.0% |
| Net Profit YoY | -141.1% | -49.4% |
| EPS (diluted) | $-0.17 | $0.13 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $13.8M | $22.3M | ||
| Q3 25 | $12.5M | $27.8M | ||
| Q2 25 | $9.7M | $21.5M | ||
| Q1 25 | $8.8M | $20.3M | ||
| Q4 24 | $7.9M | $27.2M | ||
| Q3 24 | $7.0M | $38.4M | ||
| Q2 24 | $7.3M | $34.3M | ||
| Q1 24 | $25.4M | $37.1M |
| Q4 25 | $-4.8M | $15.9M | ||
| Q3 25 | $-638.0K | $19.2M | ||
| Q2 25 | $-3.2M | $17.1M | ||
| Q1 25 | $-1.2M | $11.6M | ||
| Q4 24 | $-2.0M | $31.3M | ||
| Q3 24 | $-5.7M | $27.6M | ||
| Q2 24 | $-5.6M | $32.1M | ||
| Q1 24 | $12.8M | $16.4M |
| Q4 25 | -18.5% | 69.5% | ||
| Q3 25 | -1.5% | 72.4% | ||
| Q2 25 | -28.3% | 96.7% | ||
| Q1 25 | -9.2% | 52.7% | ||
| Q4 24 | -11.8% | — | ||
| Q3 24 | -74.6% | 74.1% | ||
| Q2 24 | -69.4% | 90.4% | ||
| Q1 24 | 54.2% | 49.4% |
| Q4 25 | -34.7% | 71.0% | ||
| Q3 25 | -5.1% | 69.0% | ||
| Q2 25 | -32.7% | 79.5% | ||
| Q1 25 | -13.3% | 56.8% | ||
| Q4 24 | -25.0% | 115.1% | ||
| Q3 24 | -82.2% | 71.7% | ||
| Q2 24 | -76.5% | 93.6% | ||
| Q1 24 | 50.6% | 44.2% |
| Q4 25 | $-0.17 | $0.13 | ||
| Q3 25 | $-0.02 | $0.15 | ||
| Q2 25 | $-0.11 | $0.14 | ||
| Q1 25 | $-0.04 | $0.09 | ||
| Q4 24 | $-0.02 | $0.25 | ||
| Q3 24 | $-0.21 | $0.22 | ||
| Q2 24 | $-0.20 | $0.26 | ||
| Q1 24 | $0.41 | $0.13 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $36.8M | $38.0M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $35.5M | $1.5B |
| Total Assets | $70.6M | $5.2B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $36.8M | $38.0M | ||
| Q3 25 | $21.9M | $49.4M | ||
| Q2 25 | $18.7M | $134.9M | ||
| Q1 25 | $22.7M | $479.8M | ||
| Q4 24 | $26.6M | $1.3B | ||
| Q3 24 | $40.3M | $1.6B | ||
| Q2 24 | $43.1M | $1.2B | ||
| Q1 24 | $51.2M | $1.2B |
| Q4 25 | — | — | ||
| Q3 25 | $19.4M | — | ||
| Q2 25 | $19.4M | — | ||
| Q1 25 | $19.4M | — | ||
| Q4 24 | $19.3M | — | ||
| Q3 24 | $32.1M | — | ||
| Q2 24 | $31.8M | — | ||
| Q1 24 | $31.3M | — |
| Q4 25 | $35.5M | $1.5B | ||
| Q3 25 | $-4.5M | $1.5B | ||
| Q2 25 | $-7.5M | $1.5B | ||
| Q1 25 | $-5.9M | $1.5B | ||
| Q4 24 | $-5.9M | $1.5B | ||
| Q3 24 | $-5.2M | $1.5B | ||
| Q2 24 | $-1.4M | $1.5B | ||
| Q1 24 | $3.0M | $1.5B |
| Q4 25 | $70.6M | $5.2B | ||
| Q3 25 | $49.3M | $4.7B | ||
| Q2 25 | $44.9M | $4.5B | ||
| Q1 25 | $46.4M | $4.5B | ||
| Q4 24 | $44.9M | $4.8B | ||
| Q3 24 | $58.9M | $4.8B | ||
| Q2 24 | $63.2M | $4.8B | ||
| Q1 24 | $69.2M | $5.3B |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 10.40× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-6.0M | $87.0M |
| Free Cash FlowOCF − Capex | — | $78.7M |
| FCF MarginFCF / Revenue | — | 352.4% |
| Capex IntensityCapex / Revenue | — | 37.4% |
| Cash ConversionOCF / Net Profit | — | 5.49× |
| TTM Free Cash FlowTrailing 4 quarters | — | $118.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-6.0M | $87.0M | ||
| Q3 25 | $1.5M | $26.3M | ||
| Q2 25 | $-3.7M | $44.0M | ||
| Q1 25 | $-4.3M | $-28.7M | ||
| Q4 24 | $-1.5M | $133.9M | ||
| Q3 24 | $-2.2M | $169.0M | ||
| Q2 24 | $-8.4M | $45.4M | ||
| Q1 24 | $39.0M | $-20.4M |
| Q4 25 | — | $78.7M | ||
| Q3 25 | — | $25.9M | ||
| Q2 25 | — | $43.4M | ||
| Q1 25 | — | $-29.6M | ||
| Q4 24 | — | $127.4M | ||
| Q3 24 | — | $166.0M | ||
| Q2 24 | — | $44.9M | ||
| Q1 24 | — | $-21.7M |
| Q4 25 | — | 352.4% | ||
| Q3 25 | — | 93.1% | ||
| Q2 25 | — | 201.6% | ||
| Q1 25 | — | -145.6% | ||
| Q4 24 | — | 468.2% | ||
| Q3 24 | — | 432.1% | ||
| Q2 24 | — | 131.0% | ||
| Q1 24 | — | -58.6% |
| Q4 25 | — | 37.4% | ||
| Q3 25 | — | 1.7% | ||
| Q2 25 | — | 2.9% | ||
| Q1 25 | — | 4.3% | ||
| Q4 24 | — | 23.9% | ||
| Q3 24 | — | 7.8% | ||
| Q2 24 | — | 1.3% | ||
| Q1 24 | — | 3.7% |
| Q4 25 | — | 5.49× | ||
| Q3 25 | — | 1.37× | ||
| Q2 25 | — | 2.57× | ||
| Q1 25 | — | -2.49× | ||
| Q4 24 | — | 4.27× | ||
| Q3 24 | — | 6.13× | ||
| Q2 24 | — | 1.41× | ||
| Q1 24 | 3.04× | -1.24× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
